Abstract
Novel Schiff’s base hydrazone derivatives (1–24) based on polyhydroquinoline (PHQ) were synthesized in good to excellent yields via three step reactions. Compound 1 (starting material) was synthesized through one pot multi-component unsymmetrical Hantzsch reaction by refluxing a mixture of ethyl-2-(2-formylphenoxy)acetate, dimedone, ammonium acetate, and ethyl acetoacetate in ethanol solvent for 6–8 h. The obtained PHQ was then refluxed with hydrazine hydrate in the presence of absolute ethanol for 4–5 h. to get compound 2. Finally, the hydrazide was treated with various substituted aromatic/aliphatic aldehydes to afford the desired hydrazone Schiff’s bases (3–24). All the produced analogues were structurally deduced with the help of LC-HRESI-MS, 1H- and 13C-NMR spectroscopy. The obtained compounds were evaluated for their α-glucosidase activity, where twelve compounds (10, 14, 7, 9, 8, 17, 12, 19, 13, 15, 21, and 11) were found the most active at IC50 ranging between 5.26 and 25.17 µM, compared to acarbose, a standard α-glucosidase inhibitor with IC50 of 873.34 ± 1.67 µM. The best hit compounds were docked within the acarbose binding pocket of α-glucosidase and vetted for their binding affinities.
Similar content being viewed by others
Availability of data and materials
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
References
A. Alam, M. Ali, N.U. Rehman, S. Ullah, S.A. Halim, A. Latif, A. Khan, O. Ullah, S. Ahmad, A. Al-Harrasi, Pharmaceuticals 15, 672 (2022)
X.-T. Xu, X.-Y. Deng, J. Chen, Q.-M. Liang, K. Zhang, D.-L. Li, P.-P. Wu, X. Zheng, R.-P. Zhou, Z.-Y. Jiang, Eur. J. Med. Chem. 189, 112013 (2020)
A. Alam, M. Ali, A. Latif, N.U. Rehman, S. Saher, A. Khan, S. Ullah, O. Ullah, S.A. Halim, F. Sani, Bioorg. Chem. 128, 106058 (2022)
C.M. Santos, M. Freitas, E. Fernandes, Eur. J. Med. Chem. 157, 1460 (2018)
M. Dhameja, P. Gupta, Eur. J. Med. Chem. 176, 343 (2019)
P. Bytzer, N.J. Talley, J. Hammer, L.J. Young, M.P. Jones, M. Horowitz, Am. J. Gastroenterol. 97, 604 (2002)
M.S. Hedrington, S.N. Davis, Expert Opin. Pharmacother. 20, 2229 (2019)
S.V. Moelands, P.L. Lucassen, R.P. Akkermans, W.J. De Grauw, F.A. Van de Laar, Cochrane Database Syst. Rev. 12, CD005061 (2018)
N.U. Rehman, R. Maqsood, S. Ullah, S.A. Halim, M.U. Anwar, A. Khan, A. Hussain, J. Hussain, A. Al-Harrasi, S. Afr. J. Bot. 148, 88 (2022)
K. Rafiq, M. Khan, N. Muhammed, A. Khan, N. Ur Rehman, B.E.M. Al-Yahyaei, M. Khiat, S.A. Halim, Z. Shah, R. Csuk, Med. Chem. Res. 30, 712 (2021)
A. Al-Mulla, Der Pharma Chem. 9, 141 (2017)
G.M. Ziarani, N.H. Nasab, N. Lashgari, RSC Adv. 6, 38827 (2016)
A. Weyesa, E. Mulugeta, RSC Adv. 10, 20784 (2020)
X.F. Shang, S.L. Morris-Natschke, Y.Q. Liu, X. Guo, X.S. Xu, M. Goto, J.C. Li, G.Z. Yang, K.H. Lee, Med. Res. Rev. 38, 775 (2018)
P. Teng, C. Li, Z. Peng, V.A. Marie, A. Nimmagadda, M. Su, Y. Li, X. Sun, J. Cai, Bioorg. Med. Chem. 26, 3573 (2018)
K. Nakamoto, I. Tsukada, K. Tanaka, M. Matsukura, T. Haneda, S. Inoue, N. Murai, S. Abe, N. Ueda, M. Miyazaki, Bioorg. Med. Chem. Lett. 20, 4624 (2010)
I.A.M. Radini, T.M. Elsheikh, E.M. El-Telbani, R.E. Khidre, Molecules 21, 909 (2016)
S. Mukherjee, M. Pal, Drug Discov. Today 18, 389 (2013)
M. Kidwai, N. Negi, Mon. Chem. Chem. Mon. 128, 85 (1997)
P. Balaji, D. Ranganayakulu, G.S. Reddy, Asian J. Pharm. Pharmacol. 3, 9 (2017)
N. Muruganantham, R. Sivakumar, N. Anbalagan, V. Gunasekaran, J.T. Leonard, Biol. Pharm. Bull. 27, 1683 (2004)
S.M. Baghbanian, S. Khaksar, S.M. Vahdat, M. Farhang, M. Tajbakhsh, Chin. Chem. Lett. 21, 563 (2010)
R.C. Brinkerhoff, E. Santa-Helena, P.C. do Amaral, D.C. Cabrera, R.F. Ongaratto, P.M. de Oliveira, C.D.R.M. D’Oca, C.A.N. Gonçalves, L.E.M. Nery, M.G.M. D’Oca, RSC Adv. 9, 24688 (2019)
K. Aswin, K. Logaiya, P.N. Sudhan, S.S. Mansoor, J. Taibah Univ. Sci. 6, 1 (2012)
S. Jadhvar, H. Kasraliker, S. Goswami, A. Chakrawar, S. Bhusare, Res. Chem. Intermed. 43, 7211 (2017)
R.R. Raslan, S.A. Hessein, S.A. Fouad, N.A. Shmiess, J. Heterocycl. Chem. 59, 832 (2022)
D.K. Jamale, S.S. Undare, N.J. Valekar, A.P. Sarkate, G.B. Kolekar, P.V. Anbhule, J. Heterocycl. Chem. 56, 608 (2019)
K. Ahmed, B. Dubey, S. Nadeem, B. Shrivastava, P. Sharma and C. Karthikeyan
A. Kumar, S. Sharma, V.D. Tripathi, R.A. Maurya, S.P. Srivastava, G. Bhatia, A. Tamrakar, A.K. Srivastava, Bioorg. Med. Chem. 18, 4138 (2010)
H. Yu, N.U. Rehman, M. Ali, A. Alam, A. Latif, N. Shahab, I. Amir Khan, A. Jabbar Shah, M. Khan, A. Al-Ghafri, Antibiotics 11, 1568 (2022)
S. Mirani Nezhad, E. Nazarzadeh Zare, A. Davarpanah, S.A. Pourmousavi, M. Ashrafizadeh, A.P. Kumar, Molecules 27, 1748 (2022)
G.H.A. Machado, M.V.C. Trento, J.J. Pinelli, R.H. Piccoli, S.S. Thomasi, S. Marcussi (2021)
N.H. Sapariya, B.K. Vaghasiya, R.P. Thummar, R.D. Kamani, K.H. Patel, P. Thakor, S.S. Thakkar, A. Ray, D.K. Raval, New J. Chem. 41, 10686 (2017)
J.D. Bhatt, T.S. Patel, C.J. Chudasama, K.D. Patel, Chem. Sel. 3, 3632 (2018)
M. Taha, N.H. Ismail, S. Imran, A. Wadood, F. Rahim, M. Ali, A.U. Rehman, MedChemComm 6, 1826 (2015)
M. Sepahvand, F. Buazar, M.H. Sayahi, Appl. Organomet. Chem. 34, e6000 (2020)
X. Zhang, G. Li, D. Wu, Y. Yu, N. Hu, H. Wang, X. Li, Y. Wu, Food Funct. 11, 66 (2020)
N. Ur Rehman, K. Rafiq, A. Khan, S. Ahsan Halim, L. Ali, N. Al-Saady, A. Hilal Al-Balushi, H.K. Al-Busaidi, A. Al-Harrasi, Mar. Drugs 17, 666 (2019)
S.A. Halim, S. Jabeen, A. Khan, A. Al-Harrasi, Pharmaceuticals 14, 482 (2021)
I. Khan, A. Khan, S.A. Halim, M. Khan, S. Zaib, B.E.M. Al-Yahyaei, A. Al-Harrasi, A. Ibrar, Int. J. Biol. Macromol. 167, 233 (2021)
Funding
This work is supported by the Higher Education Research Endowment Fund for financial support, under research project (HED-041).
Author information
Authors and Affiliations
Contributions
MA and DK: Supervision; MA and MA: Conceptualization; NS, ZZ and AA: Experimental; NUR and AA-H: Spectroscopic analysis; MK, SU and AK: Biological activities; AL and MS: Molecular docking.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shahab, N., Kong, D., Ali, M. et al. Novel polyhydroquinoline Schiff’s base derivatives: synthesis, characterization, in vitro α-glucosidase inhibitory, and molecular docking studies. Res Chem Intermed 49, 3005–3028 (2023). https://doi.org/10.1007/s11164-023-05038-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-023-05038-y